Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection: How long should it be given?

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 6, 2001, Pages 584-588

  Ogura, K ^a   Yoshida, H ^a   Maeda, S ^a   Yamaji, Y ^a   Kawabe, T ^a   Okamoto, M ^a   Shiratori, Y ^a   Omata, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Clarithromycin; Drug resistant; Eradication; Helicobacter pylori; Triple therapy

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; LANSOPRAZOLE; UREA;

ADULT; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035023948     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201750162999     Document Type: Article

References (26)

1. Randomized double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection
2. Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study
3. Reversal of fundic atrophy after eradication of Helicobacter pylori
4. Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report
5. Antibiotic resistance in Helicobacter pylori: Implications for therapy
6. Clinical relevance of resistant strains of Helicobacter pylori: A review of current data
7. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains
8. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: A prospective study of 1-week lansoprazole, amoxicillin and clarithromycin in active peptic ulcer
9. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States
10. Antimicrobial resistance in Helicobacter pylori: A global overview
11. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
12. Detection of clarithromycin-resistant Helicobacter pylori strains with preferential homo-duplex formation assay
13. Helicobacter pylori-specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance
14. One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori
15. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen
16. Lansoprazole triple therapy for Helicobacter pylori - Is 5 days enough?
17. The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen
18. 13C-urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of 'false' results, and influence of food intake
19. Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy
20. A prospective comparison of locally made rapid urease test and histology for the diagnosis of Helicobacter pylori infection
21. Determination of the optimal cut-off value for [13C] urea breath test based on a Helicobacter pylori-specific PCR assay
22. Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients
23. A simple method for detecting single base substitutions and its application to HLA-DPB1 typing
24. Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer diseases
25. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy
26. Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: An eighteen-month follow-up